Home » Topics » Regulatory » Patents

Patents
RSS

GABA-A receptor ligands disclosed by Synthelabo

Aug. 16, 1996

Meiji Seika claims bicyclic thiazoles for CNS disorders

Aug. 16, 1996

Allelix describes D4 antagonists for schizophrenia

Aug. 16, 1996

5-HT2 receptor ligands reported by Allelix

Aug. 16, 1996

Hypolipidemic agents described by Bayer

Aug. 16, 1996

RPR reports squalene synthase inhibitors

Aug. 16, 1996

Takeda claims benzothiepin derivatives to treat bone disease

Aug. 16, 1996

Cannabinoid receptor ligands for glaucoma reported by Merck Frosst

Aug. 16, 1996

Kyorin, Sagami report antineoplastic acrylamides

Aug. 16, 1996

Pola claims antisense oligonucleotides for cancer

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026